0001209191-18-055188.txt : 20181016
0001209191-18-055188.hdr.sgml : 20181016
20181016182813
ACCESSION NUMBER: 0001209191-18-055188
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20181012
FILED AS OF DATE: 20181016
DATE AS OF CHANGE: 20181016
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Zhang Eric
CENTRAL INDEX KEY: 0001753274
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36361
FILM NUMBER: 181125171
MAIL ADDRESS:
STREET 1: C/O VERSARTIS, INC.
STREET 2: 1020 MARSH ROAD
CITY: MENLO PARK
STATE: CA
ZIP: 94025
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aravive, Inc.
CENTRAL INDEX KEY: 0001513818
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 264106690
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: LYONDELLBASELL TOWER
STREET 2: 1221 MCKINNEY STREET, SUITE 3200
CITY: HOUSTON
STATE: TX
ZIP: 77010
BUSINESS PHONE: 936-355-1910
MAIL ADDRESS:
STREET 1: LYONDELLBASELL TOWER
STREET 2: 1221 MCKINNEY STREET, SUITE 3200
CITY: HOUSTON
STATE: TX
ZIP: 77010
FORMER COMPANY:
FORMER CONFORMED NAME: Versartis, Inc.
DATE OF NAME CHANGE: 20110223
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-10-12
0
0001513818
Aravive, Inc.
ARAV
0001753274
Zhang Eric
C/O ARAVIVE, INC.
LYONDELLBASEL TOWER, 1221 MCKINNEY ST.
HOUSTON
TX
77010
1
0
0
0
Common Stock
2018-10-12
4
A
0
859766
A
859766
I
See footnote
Shares of common stock of the corporation known as Aravive Biologics, Inc. ("Aravive") were converted into shares of the Issuer pursuant to that certain Agreement and Plan of Merger and Reorganization, dated as of June 3, 2018, by and among the Issuer, Velo Merger Sub, Inc. and Aravive (the "Merger Agreement"). Pursuant to the terms of the Merger Agreement, each share of Aravive common stock was exchanged for 2.2801 shares of the Issuer's common stock. Following the merger, the Issuer effected a reverse stock split at a ratio of one share for every six shares of Issuer common stock and the Issuer changed its name to Aravive, Inc. All share numbers reflect the reverse stock split.
Shares of common stock of the Issuer held by Elite Vantage Global Limited. The Reporting Person is a director of Elite Vantage Global Limited. The address for Elite Vantage Global Limited is Suite 1807, 18F, China Resources Building, 26 Harbor Road, Hong Kong. The Reporting Person disclaims beneficial ownership of the shares held by Elite Vantage Global Limited except to the extent of his pecuniary interest therein.
/s/ Kevin Haas, Attorney-in-fact
2018-10-16